---
company: Versigent PLC
ticker: VGNT
form: 8-K
filed: 2026-05-05
accession: 0002078008-26-000007
source: https://www.sec.gov/Archives/edgar/data/2078008/000207800826000007/
---

# Versigent (VGNT) earnings release, May 5, 2026

Versigent PLC (VGNT) · Form 8-K, Item 2.02 · Filed 2026-05-05 · [SEC filing](https://www.sec.gov/Archives/edgar/data/2078008/000207800826000007/)

PRESS RELEASE

Versigent Reports First Quarter 2026 Results

Strong Revenue Growth, Reaffirmed 2026 Guidance, and Introduction of Dividend Policy and Share Repurchase Program

SCHAFFHAUSEN, Switzerland, May 5, 2026 – Versigent PLC (NYSE: VGNT), a global leader in the design and manufacture of low‑ and high‑voltage electrical architectures, today reported results for its first quarter ended March 31, 2026 (“First Quarter 2026”).

Versigent operated as the Electrical Distribution Systems segment of Aptiv PLC (“Aptiv” or the “Parent”) for the entire first quarter of 2026 prior to the distribution of all of the ordinary shares of Versigent to holders of Aptiv’s ordinary shares on a pro rata basis on April 1, 2026 (the “Separation” or “Spin-Off”). Financial information presented for periods prior to April 1, 2026, have been derived from Aptiv’s accounting records and are presented on a carve‑out basis as if Versigent had operated as a standalone company for all periods presented.

First Quarter 2026 Highlights

• Revenue of $2,212 million, an increase of 9%

◦ Revenue increased 3% adjusted for currency exchange and commodity movements

• Net income attributable to Versigent of $78 million

• Adjusted EBITDA of $203 million; Adjusted EBITDA margin of 9.2%

• Cash from operations of $36 million; Free cash flow of $(30) million which includes $26 million of separation costs

Full Year 2026 Guidance

• Revenue of $9,100 million to $9,400 million; ~2% of adjusted revenue growth

• U.S. GAAP net income of $315 million to $375 million

• Adjusted EBITDA of $950 million to $1,030 million

• Cash flow from operations of $440 million to $540 million

• Free cash flow of $200 million to $300 million

“Versigent delivered strong financial results for the quarter reflecting customer demand for our differentiated solutions made possible by our commitment to disciplined operational execution,” said Joe Liotine, Chief Executive Officer, Versigent. “We entered the public markets with clarity about who we are, how we compete, and the opportunities ahead of us to unlock greater value.

Versigent launched from a position of strength as a scaled, profitable, and fundamentally resilient business.

Our First Quarter 2026 results underscore our commitment to execute consistently, design the right solutions for our customers and create long-term value for our stakeholders around the globe”.

“In the first quarter, Versigent remained focused and executed against our strategy, resulting in solid financial performance including increased revenue, a strong net income attributable to Versigent of $78 million and adjusted EBITDA of $203 million with adjusted EBITDA margins of 9.2%,” said Doug Ostermann, Chief Financial Officer, Versigent.

“We continue to operate as a highly-engineered, cash-generative business anchored by our disciplined capital allocation strategy prioritizing the right investments in our business and attractive returns for our shareholders”.

First Quarter 2026 Results

Revenue for the First Quarter 2026 was $2,212 million, an increase of 9% compared to the prior‑year period. Adjusted for the impact of foreign currency exchange and commodity pass‑through, revenue increased approximately 3% during the First Quarter 2026. Growth was driven by higher volumes in North America and Asia Pacific reflecting stronger customer demand despite lower global automotive production.

Net income attributable to Versigent was $78 million, compared to $95 million in the prior‑year period.

Adjusted EBITDA for the First Quarter 2026 totaled $203 million, compared to $198 million in the prior‑year period. Adjusted EBITDA margin was 9.2%, compared to 9.8% in the prior‑year period. Adjusted EBITDA margin reflected disciplined operating execution and higher volumes, despite headwinds related to commodity costs and foreign exchange impacts.

Interest expense for the First Quarter 2026 totaled $5 million, compared to $2 million in the prior‑year period. The increase was related to the issuance of the Company’s Senior Notes and Credit Agreement in connection with the Spin-Off.

Income tax benefit for the First Quarter 2026 was $9 million, compared to income tax expense of $29 million in the prior‑year period. The change primarily reflected discrete tax benefits recognized during the First Quarter 2026.

Net cash provided by operating activities for the First Quarter 2026 was $36 million, compared to $40 million in the prior-year period, reflecting earnings performance partially offset by working capital investment during the period. Capital expenditures totaled $66 million for the First Quarter 2026. Free cash flow was $(30) million for the First Quarter 2026, compared to $3 million in the prior-year period. The decrease in free cash flow compared to the prior-year period was primarily driven by an increase in restructuring costs, one-time separation costs and capital expenditures during the First Quarter 2026.

Capital Allocation... (truncated)ement and subject to compliance with applicable laws and regulations.

2026 Outlook

Versigent reaffirmed its full-year 2026 financial guidance as follows:

Conference Call and Webcast

Versigent will host a conference call to discuss its First Quarter 2026 financial results today, Tuesday, May 5, 2026, at 4:15 p.m. Eastern Time.

A live webcast of the conference call and related presentation materials are available on Versigent’s Investor Relations website at ir.versigent.com. A replay of the webcast will be available approximately two hours following the conclusion of the call.

To participate by telephone, please dial +1‑800‑330‑6710 (U.S.) or +1‑213‑279‑1505 (international) at least 15 minutes prior to the start of the call and reference the Versigent conference call. The conference ID number is 8379126.

About Versigent

Versigent is a global leader in the purposeful design and advanced manufacturing of low and high voltage electrical architectures. Building on a legacy of engineering excellence and trusted partnerships, Versigent delivers versatile, intelligent solutions engineered to unlock greater capabilities for our customers. Powering one in six passenger vehicles in production today, Versigent’s high performance signal, power, and data distribution systems are trusted by industry leaders across automotive, commercial vehicles, agriculture and energy storage. With engineering and manufacturing centers on four continents and operations in more than 25 countries, Versigent’s 138,000 employees match global scale with regional responsiveness to deliver consistent quality and reliable performance connecting the world to faster, smarter and safer experiences. Visit www.versigent.com.

Use of Non‑GAAP Financial Information²

This press release contains information about Versigent’s financial results which are not presented in accordance with GAAP. Specifically, Adjusted Revenue Growth, Adjusted EBITDA and Free Cash Flow are non-GAAP financial measures. Adjusted Revenue Growth represents the change in reported net sales relative to the comparable period, excluding the impact on net sales from currency exchange and commodity movements. Adjusted EBITDA represents net income (loss) before depreciation and amortization (including asset impairments), interest expense, income tax (expense) benefit, other income (expense), net, equity income (loss), net of tax, restructuring, separation costs related to the Spin-Off and other special items. Adjusted EBITDA margin represents Adjusted EBITDA as a percentage of net sales. Free Cash Flow represents cash provided by (used in) operating activities less capital expenditures.

Management believes the non-GAAP financial measures used in this press release are useful to both management and investors in their analysis of the Company’s financial position, results of operations and liquidity. In particular, management believes Adjusted Revenue Growth, Adjusted EBITDA and Free Cash Flow are useful measures in assessing the Company’s ongoing financial performance that, when reconciled to the corresponding GAAP measure, provide improved comparability between periods through the exclusion of certain items that management believes are not indicative of the Company’s core operating performance and that may obscure underlying business results and trends. Management also uses these non-GAAP financial measures for internal planning and forecasting purposes.

Such non-GAAP financial measures are reconciled to the most directly comparable GAAP financial measures in the attached supplemental schedules at the end of this press release. Non-GAAP measures should not be considered in isolation or as a substitute for our reported results prepared in accordance with GAAP and, as calculated, may not be comparable to other similarly titled measures of other companies.

Forward‑Looking Statements

This press release contains forward-looking statements that reflect, when made, Versigent’s current views with respect to current events, business plans and financial performance. Such forward-looking statements are subject to many risks, uncertainties and factors relating to Versigent’s operations and business environment, which may cause the actual results of Versigent to be materially different from any future results. All statements that address future operating, financial or business performance or Versigent’s strategies or expectations are forward-looking statements. Factors that could cause actual results to differ materially from these forward-looking statements include, but are not limited to, the following: disruptions in the supply of raw materials and other supplies integral to our products; future significant public health crises and other global health crises and the measures taken in response thereto; a prolonged recession and/or a downturn in global automotive sales; the volatile global economic environment and geopolitical conditions, including conditions affecting the credit market and global inflationary pressures; our reliance on relationships with collaborative partners and other third parties for product development and such parties’ failure to perform; employee strikes and labor-related disruptions involving us or one or more of our customers affecting our operations; fluctuations in interest rates and foreign currency exchange rates; our failure to comply with the numerous laws and regulations to which we are subject; adverse developments affecting one or more of our suppliers; any adverse impact of legal proceedings and disputes in which we are involved; challenges to our historical and future tax positions by taxing authorities; an increase in our tax burden due to ongoing or future tax audits; our failure to attract and retain key salaried employees and management personnel; our failure to manage the transition to a standalone public company; our failure to achieve some or all of the benefits expected from the Spin-Off and other risks related to the completion of the Spin-Off. Additional factors are discussed under the captions “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Versigent’s filings with the Securities and Exchange Commission. New risks and uncertainties arise from time to time, and it is impossible for us to predict these events or how they may affect Versigent. Versigent disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events and/or otherwise, except as may be required by law.³

## Financial statements

### Income Statement (Full-Year 2026 — Versigent reaffirmed its full-year 2026 financial guidance as follows: (in millions))

| | Full-Year 2026 |
|---|---:|
| Revenue | $9,100 - $9,400 |
| U.S. GAAP net income | $315 - $375 |
| Adjusted EBITDA | $950 - $1,030 |
| Cash flow from operations | $440 - $540 |
| Free cash flow | $200 - $300 |

### Income Statement (Three Months Ended March 31, — (Unaudited) (in millions))

| | Three Months Ended March 31, – 2026 | Three Months Ended March 31, – 2025 |
|---|---:|---:|
| Net sales | 2,212 | 2,024 |
| Operating expenses: | Cost of sales | 1,968 | 1,775 |
| Operating expenses: | Selling, general and administrative | 97 | 105 |
| Operating expenses: | Amortization | 1 |  |
| Operating expenses: | Restructuring | 46 | 16 |
| Operating expenses: | Separation costs | 26 | 5 |
| Operating expenses: | Total operating expenses | 2,138 | 1,901 |
| Operating expenses: | Operating income | 74 | 123 |
| Operating expenses: | Interest expense | -5 | -2 |
| Operating expenses: | Other expense, net | -1 | -1 |
| Operating expenses: | Income before income taxes and equity income | 68 | 120 |
| Operating expenses: | Income tax benefit (expense) | 9 | -29 |
| Operating expenses: | Income before equity income | 77 | 91 |
| Operating expenses: | Equity income, net of tax | 4 | 5 |
| Operating expenses: | Net income | 81 | 96 |
| Operating expenses: | Net income attributable to noncontrolling interest | 3 | 1 |
| Operating expenses: | Net income attributable to Versigent | 78 | 95 |

### Income Statement (Three Months Ended March 31, (in millions))

| | Three Months Ended March 31, – 2026 | Three Months Ended March 31, – 2025 |
|---|---:|---:|
| Net income attributable to Versigent | 78 | 95 |
| Interest expense | 5 | 2 |
| Income tax (benefit) expense | -9 | 29 |
| Net income attributable to noncontrolling interest | 3 | 1 |
| Depreciation and amortization | 61 | 52 |
| EBITDA | 138 | 179 |
| Other expense, net | 1 | 1 |
| Equity income, net | -4 | -5 |
| Restructuring | 46 | 16 |
| Separation costs | 26 | 5 |
| Net gain on lease terminations | -4 |  |
| Other acquisition and portfolio project costs |  | 2 |
| Adjusted EBITDA | 203 | 198 |
| Adjusted EBITDA Margin | 9.2 | 9.8 |

### Income Statement (in millions)

| |  |
|---|---:|
| Adjusted EBITDA | Net income attributable to Versigent | 345 |
| Adjusted EBITDA | Interest expense | 105 |
| Adjusted EBITDA | Income tax expense | 100 |
| Adjusted EBITDA | Net income attributable to noncontrolling interest | 15 |
| Adjusted EBITDA | Depreciation and amortization | 235 |
| Adjusted EBITDA | EBITDA | 800 |
| Adjusted EBITDA | Other expense, net | 10 |
| Adjusted EBITDA | Equity income, net of tax | -15 |
| Adjusted EBITDA | Restructuring | 115 |
| Adjusted EBITDA | Separation costs and other special items | 80 |
| Adjusted EBITDA | 990 |
| Adjusted EBITDA | Adjusted EBITDA Margin | 10.7 |

### Balance Sheet ((Unaudited) (in millions))

| | March 31, 2026 – (Unaudited) | December 31, 2025 |
|---|---:|---:|
| Current assets: | Cash and cash equivalents | 282 | 276 |
| Current assets: | Accounts receivable, net | 1,829 | 1,567 |
| Current assets: | Inventories | 784 | 772 |
| Current assets: | Other current assets | 251 | 158 |
| Current assets: | Total current assets | 3,146 | 2,773 |
| Long-term assets: | Property, net | 896 | 901 |
| Long-term assets: | Operating lease right-of-use assets | 182 | 168 |
| Long-term assets: | Investments in affiliates | 142 | 143 |
| Long-term assets: | Intangible assets, net | 7 | 7 |
| Long-term assets: | Deferred tax assets | 402 | 384 |
| Long-term assets: | Other long-term assets | 134 | 109 |
| Long-term assets: | Total long-term assets | 1,763 | 1,712 |
| Long-term assets: | Total assets | 4,909 | 4,485 |
| Current liabilities: | Short-term debt | 67 | 58 |
| Current liabilities: | Accounts payable | 1,532 | 1,530 |
| Current liabilities: | Accrued liabilities | 676 | 578 |
| Current liabilities: | Total current liabilities | 2,275 | 2,166 |
| Long-term liabilities: | Long-term debt | 2,074 | 3 |
| Long-term liabilities: | Pension benefit obligations | 207 | 217 |
| Long-term liabilities: | Long-term operating lease liabilities | 137 | 130 |
| Long-term liabilities: | Other long-term liabilities | 73 | 121 |
| Long-term liabilities: | Total long-term liabilities | 2,491 | 471 |
| Long-term liabilities: | Total liabilities | 4,766 | 2,637 |
| Net parent equity: | Net parent investment | 164 | 1,925 |
| Net parent equity: | Accumulated other comprehensive loss | -212 | -268 |
| Net parent equity: | Total parent (deficit) equity | -48 | 1,657 |
| Net parent equity: | Noncontrolling interest | 191 | 191 |
| Net parent equity: | Total invested equity | 143 | 1,848 |
| Net parent equity: | Total liabilities and invested equity | 4,909 | 4,485 |

### Cash Flow (Three Months Ended March 31, — (Unaudited) (in millions))

| | Three Months Ended March 31, – 2026 | Three Months Ended March 31, – 2025 |
|---|---:|---:|
| Net cash provided by operating activities | 36 | 40 |
| Cash flows from investing activities: | Capital expenditures | -66 | -37 |
| Cash flows from investing activities: | Net cash used in investing activities | -66 | -37 |
| Cash flows from financing activities: | Net proceeds (repayments) under short-term debt agreements - outside parties | 9 | -72 |
| Cash flows from financing activities: | Net proceeds under short-term debt agreements - related parties |  | 12 |
| Cash flows from financing activities: | Proceeds from issuance of senior notes and credit agreement, net of issuance costs | 2,063 |  |
| Cash flows from financing activities: | Cash distribution paid to Parent | -1,900 |  |
| Cash flows from financing activities: | Net transfers (to) from Parent | -130 | 39 |
| Cash flows from financing activities: | Dividend payments of consolidated affiliates to minority shareholders | -4 |  |
| Cash flows from financing activities: | Net cash provided by (used in) financing activities | 38 | -21 |
| Cash flows from financing activities: | Effect of exchange rate fluctuations on cash and cash equivalents | -2 | 4 |
| Cash flows from financing activities: | Increase (decrease) in cash and cash equivalents | 6 | -14 |
| Cash flows from financing activities: | Cash and cash equivalents at beginning of the period | 276 | 201 |

### Cash Flow (Three Months Ended March 31, (in millions))

| | Three Months Ended March 31, – 2026 | Three Months Ended March 31, – 2025 |
|---|---:|---:|
| Net cash provided by operating activities | 36 | 40 |
| Capital expenditures | -66 | -37 |
| Free cash flow | -30 | 3 |

### Cash Flow (in millions)

| | Estimated Full Year – 2026 (a) |
|---|---:|
| Free Cash Flow | Net cash provided by operating activities | 490 |
| Free Cash Flow | Capital expenditures | -240 |
| Free Cash Flow | Free cash flow | 250 |
